ACA
Atlas Capital Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.07M | Sell |
7,758
-700
| -8% | -$368K | 0.5% | 49 |
|
2025
Q1 | $5.36M | Sell |
8,458
-8
| -0.1% | -$5.07K | 0.67% | 42 |
|
2024
Q4 | $6.03M | Buy |
8,466
+8,318
| +5,620% | +$5.93M | 0.77% | 37 |
|
2024
Q3 | $156K | Sell |
148
-8,334
| -98% | -$8.76M | 0.02% | 416 |
|
2024
Q2 | $8.91M | Buy |
8,482
+8,331
| +5,517% | +$8.76M | 1.16% | 21 |
|
2024
Q1 | $145K | Sell |
151
-8,334
| -98% | -$8.02M | 0.02% | 424 |
|
2023
Q4 | $7.45M | Hold |
8,485
| – | – | 1.08% | 22 |
|
2023
Q3 | $6.98M | Hold |
8,485
| – | – | 1.15% | 21 |
|
2023
Q2 | $6.1M | Sell |
8,485
-2
| -0% | -$1.44K | 0.92% | 25 |
|
2023
Q1 | $6.97M | Hold |
8,487
| – | – | 1.1% | 23 |
|
2022
Q4 | $6.12M | Hold |
8,487
| – | – | 1.03% | 24 |
|
2022
Q3 | $5.85M | Sell |
8,487
-15
| -0.2% | -$10.3K | 1.06% | 21 |
|
2022
Q2 | $5.03M | Buy |
8,502
+20
| +0.2% | +$11.8K | 0.85% | 26 |
|
2022
Q1 | $5.92M | Buy |
8,482
+9
| +0.1% | +$6.29K | 0.92% | 29 |
|
2021
Q4 | $5.35M | Hold |
8,473
| – | – | 0.8% | 31 |
|
2021
Q3 | $5.13M | Hold |
8,473
| – | – | 0.82% | 30 |
|
2021
Q2 | $4.73M | Hold |
8,473
| – | – | 0.79% | 29 |
|
2021
Q1 | $4.01M | Sell |
8,473
-296
| -3% | -$140K | 0.78% | 29 |
|
2020
Q4 | $4.24M | Sell |
8,769
-340
| -4% | -$164K | 0.89% | 27 |
|
2020
Q3 | $5.1M | Buy |
9,109
+530
| +6% | +$297K | 1.21% | 16 |
|
2020
Q2 | $5.35M | Buy |
8,579
+121
| +1% | +$75.5K | 1.26% | 12 |
|
2020
Q1 | $4.13M | Hold |
8,458
| – | – | 1.23% | 14 |
|
2019
Q4 | $3.18M | Hold |
8,458
| – | – | 0.79% | 24 |
|
2019
Q3 | $2.35M | Hold |
8,458
| – | – | 0.71% | 23 |
|
2019
Q2 | $2.65M | Hold |
8,458
| – | – | 0.87% | 16 |
|
2019
Q1 | $3.47M | Hold |
8,458
| – | – | 1.25% | 11 |
|
2018
Q4 | $3.16M | Hold |
8,458
| – | – | 1.27% | 10 |
|
2018
Q3 | $3.41M | Hold |
8,458
| – | – | 1.14% | 15 |
|
2018
Q2 | $3.09M | Hold |
8,458
| – | – | 1.1% | 14 |
|
2018
Q1 | $2.91M | Buy |
+8,458
| New | +$2.91M | 0.89% | 15 |
|